BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36334623)

  • 21. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
    Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
    Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular determinants for Csk-catalyzed tyrosine phosphorylation of the Src tail.
    Wang D; Huang XY; Cole PA
    Biochemistry; 2001 Feb; 40(7):2004-10. PubMed ID: 11329267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tnk1/Kos1: a novel tumor suppressor.
    May WS; Hoare K; Hoare S; Reinhard MK; Lee YJ; Oh SP
    Trans Am Clin Climatol Assoc; 2010; 121():281-92; discussion 292-3. PubMed ID: 20697568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Itk tyrosine kinase: contribution of noncatalytic domains to enzymatic activity.
    Hawkins J; Marcy A
    Protein Expr Purif; 2001 Jul; 22(2):211-9. PubMed ID: 11437596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thirty-eight-negative kinase 1 (TNK1) facilitates TNFalpha-induced apoptosis by blocking NF-kappaB activation.
    Azoitei N; Brey A; Busch T; Fulda S; Adler G; Seufferlein T
    Oncogene; 2007 Oct; 26(45):6536-45. PubMed ID: 17471239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation loop phosphorylation modulates Bruton's tyrosine kinase (Btk) kinase domain activity.
    Lin L; Czerwinski R; Kelleher K; Siegel MM; Wu P; Kriz R; Aulabaugh A; Stahl M
    Biochemistry; 2009 Mar; 48(9):2021-32. PubMed ID: 19206206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation of synthetic peptides containing Tyr-Met-X-Met motifs by nonreceptor tyrosine kinases in vitro.
    Garcia P; Shoelson SE; George ST; Hinds DA; Goldberg AR; Miller WT
    J Biol Chem; 1993 Nov; 268(33):25146-51. PubMed ID: 8227078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substrate recognition of PLCγ1 via a specific docking surface on Itk.
    Xie Q; Joseph RE; Fulton DB; Andreotti AH
    J Mol Biol; 2013 Feb; 425(4):683-96. PubMed ID: 23219468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The SH3 domain of Bruton's tyrosine kinase displays altered ligand binding properties when auto-phosphorylated in vitro.
    Morrogh LM; Hinshelwood S; Costello P; Cory GO; Kinnon C
    Eur J Immunol; 1999 Jul; 29(7):2269-79. PubMed ID: 10427990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subdomain switching reveals regions that harbor substrate specificity and regulatory properties of protein tyrosine kinases.
    Wang YH; Huang K; Lin X; Sun G
    Biochemistry; 2007 Sep; 46(35):10162-9. PubMed ID: 17691821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the Lck Src homology 2 and 3 domains in protein tyrosine phosphorylation.
    Lee-Fruman KK; Collins TL; Burakoff SJ
    J Biol Chem; 1996 Oct; 271(40):25003-10. PubMed ID: 8798782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyrosine phosphorylation regulates the SH3-mediated binding of the Wiskott-Aldrich syndrome protein to PSTPIP, a cytoskeletal-associated protein.
    Wu Y; Spencer SD; Lasky LA
    J Biol Chem; 1998 Mar; 273(10):5765-70. PubMed ID: 9488710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk.
    Oda A; Ochs HD; Lasky LA; Spencer S; Ozaki K; Fujihara M; Handa M; Ikebuchi K; Ikeda H
    Blood; 2001 May; 97(9):2633-9. PubMed ID: 11313252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein-tyrosine kinase and GTPase signals cooperate to phosphorylate and activate Wiskott-Aldrich syndrome protein (WASP)/neuronal WASP.
    Torres E; Rosen MK
    J Biol Chem; 2006 Feb; 281(6):3513-20. PubMed ID: 16293614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Docking-based substrate recognition by the catalytic domain of a protein tyrosine kinase, C-terminal Src kinase (Csk).
    Lee S; Ayrapetov MK; Kemble DJ; Parang K; Sun G
    J Biol Chem; 2006 Mar; 281(12):8183-9. PubMed ID: 16439366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced phosphorylation of Src family kinase substrates containing SH2 domain binding sites.
    Pellicena P; Stowell KR; Miller WT
    J Biol Chem; 1998 Jun; 273(25):15325-8. PubMed ID: 9624111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common in vitro substrate specificity and differential Src homology 2 domain accessibility displayed by two members of the Src family of protein-tyrosine kinases, c-Src and Hck.
    Sicilia RJ; Hibbs ML; Bello PA; Bjorge JD; Fujita DJ; Stanley IJ; Dunn AR; Cheng HC
    J Biol Chem; 1998 Jul; 273(27):16756-63. PubMed ID: 9642231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTB domain-directed substrate targeting in a tyrosine kinase from the unicellular choanoflagellate Monosiga brevicollis.
    Prieto-Echagüe V; Chan PM; Craddock BP; Manser E; Miller WT
    PLoS One; 2011 Apr; 6(4):e19296. PubMed ID: 21541291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemistry of the Src protein-tyrosine kinase: regulation by SH2 and SH3 domains.
    Liu X; Pawson T
    Recent Prog Horm Res; 1994; 49():149-60. PubMed ID: 7511826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.